Developing a Resilience Intervention for Older, HIV-Infected Women

为感染艾滋病毒的老年妇女制定复原力干预措施

基本信息

  • 批准号:
    9269797
  • 负责人:
  • 金额:
    $ 23.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-05-01 至 2020-01-31
  • 项目状态:
    已结题

项目摘要

Abstract HIV is no longer an acutely fatal disease. In fact, individuals living with HIV in the U.S. can now expect to live close to a normal lifespan with ongoing medical care. As a result, the population of individuals in the U.S. living with HIV is aging. Older, HIV-infected women are at risk for worse health outcomes than men. For example, older HIV-infected women experience greater levels of chronic pain and fatigue than their male counterparts, report lower levels of health related quality of life than men, and experience greater numbers of HIV-related health events and greater mortality than men. With respect to psychological and behavioral challenges, older HIV-infected women experience high rates of depression, challenges negotiating healthy sexuality, social isolation, stigma, and reduced adherence to antiretroviral therapy. Stress can worsen or perpetuate chronic illnesses, such as HIV. Few interventions to manage the stress of managing a life threatening illness have been developed for older adults with HIV; none focus on women, nor do existing interventions use a “strengths based” approach, such as developing skills that lead to greater resilience. To lay the groundwork for this work, we collected formative, qualitative data from HIV-infected women over 50 on the experience of aging as a woman with HIV in order to understand stressors and needs unique to this population. These data highlighted ways in which older women can be resilient in the face of HIV. Our colleagues at the Benson-Henry Institute for Mind-Body Medicine at Massachusetts General Hospital have developed a mind-body medicine resiliency intervention (“3RP intervention”) based on over 40 years of clinical work and research that has shown to decrease medical symptoms (overall, blood pressure, headaches, improved sleep, medication reduction), anxiety, distress, and stress among a variety of medical populations. The goal of this application is to refine and tailor the 3RP intervention to meet the specific needs of older, HIV-infected women and to complete a pilot study that will yield information on the acceptability and feasibility of studying the intervention in this group of patients. We will investigate the acceptability and feasibility in two phases. After we refine the intervention, we will test the intervention among two small groups of older, HIV-infected women. After we make any necessary changes, we will then conduct a small randomized pilot in which participants are randomized to the revised 3RP intervention or a control group. The data from this study will inform a larger study to further test the effect of the intervention and to investigate how to best deliver it so it can benefit as many older, HIV-infected women as possible.
摘要 艾滋病毒不再是一种致命的疾病。事实上,美国艾滋病毒感染者现在可以预期 在持续的医疗护理下接近正常的寿命。因此,美国的人口生活在 艾滋病病毒是衰老。感染艾滋病毒的老年妇女的健康状况可能比男子差。比如说, 感染艾滋病毒的老年妇女比她们的男性同行经历更大程度的慢性疼痛和疲劳, 报告与健康有关的生活质量水平低于男性, 健康事件和死亡率高于男性。在心理和行为挑战方面,老年人 感染艾滋病毒的妇女抑郁症的发生率很高, 隔离、污名化和抗逆转录病毒治疗依从性降低。压力会恶化或延续慢性 疾病,如艾滋病。很少有干预措施来管理管理威胁生命的疾病的压力, 针对感染艾滋病毒的老年人开发的;没有一个针对妇女,现有的干预措施也没有使用“优势”, 基于”的方法,如发展技能,导致更大的弹性。为了为这项工作奠定基础, 我们从50岁以上的HIV感染妇女中收集了关于衰老经历的形成性定性数据, 为了了解这一人群特有的压力源和需求,这些数据突出了 老年妇女在面对艾滋病毒时能够有复原力的方式。我们在本森-亨利研究所的同事 马萨诸塞州总医院的身心医学已经开发出一种身心医学弹性 基于40多年的临床工作和研究, 减少医学症状(总体而言,血压,头痛,改善睡眠,减少药物), 焦虑、痛苦和压力在不同的医疗人群中。此应用程序的目标是细化 调整3RP干预措施,以满足老年艾滋病毒感染妇女的具体需求,并完成试点 研究,将产生关于在这一群体中研究干预措施的可接受性和可行性的信息。 患者我们将分两个阶段研究其可接受性和可行性。在我们完善干预措施后,我们 将在两小群感染艾滋病病毒的老年妇女中测试这种干预措施。在我们做出任何必要的 改变后,我们将进行一个小的随机试点,其中参与者被随机分配到修订后的 3RP干预或对照组。这项研究的数据将为更大规模的研究提供信息,以进一步测试这种效果。 并研究如何最好地提供这种干预,使更多的老年艾滋病毒感染妇女受益。 越好.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christina Psaros其他文献

Christina Psaros的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christina Psaros', 18)}}的其他基金

Developing a resiliency intervention to support healthcare workers engaged in the provision of HIV care
制定弹性干预措施,支持从事艾滋病毒护理的医护人员
  • 批准号:
    10402106
  • 财政年份:
    2022
  • 资助金额:
    $ 23.23万
  • 项目类别:
Developing a resiliency intervention to support healthcare workers engaged in the provision of HIV care
制定弹性干预措施,支持从事艾滋病毒护理的医护人员
  • 批准号:
    10701868
  • 财政年份:
    2022
  • 资助金额:
    $ 23.23万
  • 项目类别:
Falling off the HIV treatment cascade cliff: understanding postpartum attrition to HIV care
摆脱艾滋病毒治疗级联悬崖:了解艾滋病毒护理的产后流失
  • 批准号:
    10196960
  • 财政年份:
    2017
  • 资助金额:
    $ 23.23万
  • 项目类别:
Perinatal Depression, Stigma, Social Capital Utilization and PMTCT Adherence
围产期抑郁、耻辱、社会资本利用和 PMTCT 依从性
  • 批准号:
    8653988
  • 财政年份:
    2012
  • 资助金额:
    $ 23.23万
  • 项目类别:
Perinatal Depression, Stigma, Social Capital Utilization and PMTCT Adherence
围产期抑郁、耻辱、社会资本利用和 PMTCT 依从性
  • 批准号:
    9059774
  • 财政年份:
    2012
  • 资助金额:
    $ 23.23万
  • 项目类别:
Perinatal Depression, Stigma, Social Capital Utilization and PMTCT Adherence
围产期抑郁、耻辱、社会资本利用和 PMTCT 依从性
  • 批准号:
    8517205
  • 财政年份:
    2012
  • 资助金额:
    $ 23.23万
  • 项目类别:
Perinatal Depression, Stigma, Social Capital Utilization and PMTCT Adherence
围产期抑郁、耻辱、社会资本利用和 PMTCT 依从性
  • 批准号:
    8263521
  • 财政年份:
    2012
  • 资助金额:
    $ 23.23万
  • 项目类别:
Perinatal Depression, Stigma, Social Capital Utilization and PMTCT Adherence
围产期抑郁、耻辱、社会资本利用和 PMTCT 依从性
  • 批准号:
    8836423
  • 财政年份:
    2012
  • 资助金额:
    $ 23.23万
  • 项目类别:
Fifteen years of epidemic HIV: Novel risk behavior in South African teens in 2010
艾滋病毒流行十五年:2010 年南非青少年的新危险行为
  • 批准号:
    8243516
  • 财政年份:
    2011
  • 资助金额:
    $ 23.23万
  • 项目类别:
Fifteen years of epidemic HIV: Novel risk behavior in South African teens in 2010
艾滋病毒流行十五年:2010 年南非青少年的新危险行为
  • 批准号:
    8140660
  • 财政年份:
    2011
  • 资助金额:
    $ 23.23万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 23.23万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了